| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/20/2008 | WO2000074709A3 Modified biodegradable polyester microspheres for stabilizing and improving the release profile of drugs encapsulated within the microspheres |
| 03/20/2008 | US20080071253 Osmotic Delivery System Flow Modulator Apparatus and Method |
| 03/20/2008 | US20080071252 Method of actuating implanted medical device |
| 03/20/2008 | US20080071233 Pharmaceutical compositions |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070981 Water-soluble compositions of bioactive lipophilic compounds |
| 03/20/2008 | US20080070978 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure |
| 03/20/2008 | US20080070897 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component (ethanol) , a surfactant such as polyglycerol, polyoxyethylene castor oil |
| 03/20/2008 | US20080070878 Foaming composition for washing and treating hair and/or scalp based on an active principle |
| 03/20/2008 | US20080070844 Method for treating wounds to promote healing |
| 03/20/2008 | US20080070789 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 03/20/2008 | US20080070301 Preparing xenograft of pig pancreatic tissue for use in prevention and treatment of diabetic disorders; antidiabetic agents |
| 03/20/2008 | US20080069902 For example, glycerol initiated multiarm polyethylene glycol modified with a polypeptide and then conjugated to a drug such as 5-fluorouracil; high drug-carrying capability; useful for hydrophilic and charge-bearing drugs as well |
| 03/20/2008 | US20080069898 Therapy for skin disorders; acne and antidandruff agent |
| 03/20/2008 | US20080069892 Mixture of agrochemical active materials and poly(urea) urethane; controlling particle size |
| 03/20/2008 | US20080069891 Abuse resistant drug formulation |
| 03/20/2008 | US20080069890 Method for treating patients with implants of islets which have been kept in long term, in vitro culture |
| 03/20/2008 | US20080069889 Mixture of polysaccharide and binder; reverse agglomeration |
| 03/20/2008 | US20080069888 Modified release formulations of at least one form of tramadol |
| 03/20/2008 | US20080069887 using an aminoorganosilane and alkylation agent; one-pot synthesis |
| 03/20/2008 | US20080069886 Spironolactone nanoparticles, compositions and methods related thereto |
| 03/20/2008 | US20080069885 Sustained release microparticle; a biodegradable and biocompatible polymer; active agent risperidone, 9-hydroxy-risperidone; pharmaceutically acceptable acid addition salts; inhibiting serotonergic or dopaminergic overstimulation |
| 03/20/2008 | US20080069884 Administered intraarticular into synovial fluid; water soluble |
| 03/20/2008 | US20080069883 Applying to body tissue; adjust circulation; mixture containing penetration intensifiers, polymeric thickener, lipophic compound , water and buffer |
| 03/20/2008 | US20080069882 Mixture of active material in matrix of fatty alcohol or acid and solid hydrocarbon; microsphere |
| 03/20/2008 | US20080069881 Abuse-resistant controlled-release opioid dosage form |
| 03/20/2008 | US20080069880 Enrobed core |
| 03/20/2008 | US20080069879 Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof |
| 03/20/2008 | US20080069878 Mixture of drug with mixture of water insoluble polymer and enteric polymer coating |
| 03/20/2008 | US20080069877 Chewable, Suckable and Swallowable Tablet Containing a Calcium-Containing Compound as an Active Substance |
| 03/20/2008 | US20080069876 Hygiene or cleaning compound; dilution with liquid |
| 03/20/2008 | US20080069875 Mixture of active material and graft polymers of polyvinyl alcohol and |
| 03/20/2008 | US20080069874 Kits for Prevention and Treatment of Rhinitis |
| 03/20/2008 | US20080069873 Controlled release system and method for manufacturing the same |
| 03/20/2008 | US20080069872 Maintenance of therapeutic concentration in blood; core with protective coating |
| 03/20/2008 | US20080069871 Hydrophobic abuse deterrent delivery system |
| 03/20/2008 | US20080069870 Pulsed release; oral administering |
| 03/20/2008 | US20080069869 Formulations and methods for modulating satiety |
| 03/20/2008 | US20080069868 Irinotecan Preparation |
| 03/20/2008 | US20080069867 Diagnostic and/or Remedy for Ovarian Cancer |
| 03/20/2008 | US20080069866 Immunotherapeutic methods and compositions |
| 03/20/2008 | US20080069865 Congestive heart failure; antiischemic agents; administering calcitonin gene related peptide in thermoplastic biocompatible polymer; controlled release or maintenance therapy |
| 03/20/2008 | US20080069863 Device for treatment of disorders in the oral cavity with nitric oxide, and manufacturing process for the same |
| 03/20/2008 | US20080069859 Method for treating neovascularization and intravitreal implants |
| 03/20/2008 | US20080069857 Aqueous solution containing polysaccharides; insertion into body cavity; crosslinking |
| 03/20/2008 | US20080069851 Substituted n-aminomethylene sulfonamides, production and use thereof as medicaments |
| 03/20/2008 | US20080069850 Drug delivery; releasing drug from substrate loaded with active materials; contraceptive, bactericides, fungicides, viricides; sustained release |
| 03/20/2008 | US20080069849 Genetic engineered polypeptide; bactericides, viricides, fungicides, parasiticides |
| 03/20/2008 | US20080069848 Device, method, and use for treatment of neuropathy involving nitric oxide |
| 03/20/2008 | US20080069793 Surfactant-free cosmetic, dermatological and pharmaceutical agents |
| 03/20/2008 | US20080069780 Triethylene glycol, dipropylene glycol, propylene glycol; need to shake the container prior to use is eliminated; leave little or no visible residue on hard surfaces |
| 03/20/2008 | US20080069779 Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof |
| 03/20/2008 | US20080069778 Polymer-encapsulated microspheres |
| 03/20/2008 | US20080066744 Process for producing metered dose inhaler formulations |
| 03/20/2008 | US20080066675 Temperature activated systems |
| 03/20/2008 | DE102006040772A1 Polymermatrix, Verfahren zu deren Herstellung sowie deren Verwendung Polymer matrix, process for their preparation and their use |
| 03/20/2008 | DE102006040123A1 Verfahren zur Herstellung von Mikropartikeln Process for the preparation of microparticles |
| 03/20/2008 | DE10120092B4 Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung Gastro-resistant device for releasing of mucoadhesive drug carriers and procedures for preparing the enteric device |
| 03/20/2008 | DE10080167B4 Medikament zur Hemmung der Expression eines vorgegebenen Gens Medicament for inhibiting the expression of a given gene |
| 03/20/2008 | CA2664315A1 Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| 03/20/2008 | CA2664311A1 Granulate containing a pharmaceutically active substance and method for its manufacture |
| 03/20/2008 | CA2663548A1 Pharmaceutical compositions for the oral or rectal administration of protein substances |
| 03/20/2008 | CA2663451A1 Rapidly disintegrating tablets in buccal cavity and manufacturing method thereof |
| 03/20/2008 | CA2663311A1 Pharmaceutical formulations comprising clopidogrel |
| 03/20/2008 | CA2663297A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders |
| 03/20/2008 | CA2663172A1 Abuse resistant drug formulation |
| 03/20/2008 | CA2663132A1 Acetylenic compounds |
| 03/20/2008 | CA2662978A1 Hindered ester-based biodegradable linkers for oligonucleotide delivery |
| 03/20/2008 | CA2662973A1 Lysine-based polymeric linkers |
| 03/20/2008 | CA2662956A1 Oral modified release formulations |
| 03/20/2008 | CA2662938A1 Light-stable solid pharmaceutical composition of ramosetron |
| 03/20/2008 | CA2662563A1 Compositions for photoprotection |
| 03/20/2008 | CA2662542A1 Pharmaceutical composition comprising a plurality of mini-tablets comprising a factor xa inhibitor |
| 03/20/2008 | CA2661892A1 Gel type enteral nutrient |
| 03/19/2008 | EP1900736A1 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same |
| 03/19/2008 | EP1900368A1 Tablet containing hardly soluble active ingredient |
| 03/19/2008 | EP1900359A1 Oral modified release formulations containing drospirenon and 8-prenylnaringenin for use in female contraception |
| 03/19/2008 | EP1900358A1 Pharmaceutical formulations comprising clopidogrel |
| 03/19/2008 | EP1900357A2 Drug delivery system for hydrophobic drugs |
| 03/19/2008 | EP1900283A2 Encapsulation of components into edible products |
| 03/19/2008 | EP1898954A1 Composition and dosage form comprising a solid or semi-solid matrix |
| 03/19/2008 | EP1898945A2 Airway administration of site-inactivated fviia in inflammatory conditions affecting the respiratory tract |
| 03/19/2008 | EP1898939A2 Compositions and methods for less immunogenic pr0tein-lip1d complexes |
| 03/19/2008 | EP1898922A2 Improved drug or pharmaceutical compounds and a preparation thereof |
| 03/19/2008 | EP1898904A2 Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| 03/19/2008 | EP1898901A2 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
| 03/19/2008 | EP1898891A2 Multilayer drug delivery system with barrier against antagonist exposure |
| 03/19/2008 | EP1898890A1 Modified and immediate release memantine bead formulation |
| 03/19/2008 | EP1898889A2 Gellan seamless breakable capsule and process for manufacturing thereof |
| 03/19/2008 | EP1898888A2 Formulations of conjugated estrogens and bazedoxifene |
| 03/19/2008 | EP1898887A2 An electro-osmotic fluid delivery device and method |
| 03/19/2008 | EP1898886A2 Novel sustained release dosage form |
| 03/19/2008 | EP1898885A1 Methods and dosage forms for reducing side effects of carbamate compounds |
| 03/19/2008 | EP1898884A2 Manufacturing process for tigecycline |
| 03/19/2008 | EP1898882A2 Nanoparticulate ebastine formulations |
| 03/19/2008 | EP1898881A2 Bioresorbable polymer matrices and methods of making and using the same |
| 03/19/2008 | EP1898880A2 Gel compositions for topical administration |
| 03/19/2008 | EP1898879A1 Rapidly absorbing oral formulations of pde5 inhibitors |
| 03/19/2008 | EP1898878A2 Drug/polymer composite materials and methods of making the same |